Document Detail

Comparison of the long-term efficacy of low dose 131I versus antithyroid drugs in the treatment of hyperthyroidism.
MedLine Citation:
PMID:  19194213     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: In China the therapeutic options to treat hyperthyroidism comprise antithyroid drugs (ATDs), radioiodine (131I) therapy and surgery. Physicians in China avoid the risk of hypothyroidism as a consequence of either treatment because patients from rural districts cannot easily comply with long-term medication. Therefore, we prospectively assessed the efficacy and safety of 131I versus ATDs. METHODS: Of 2021 hyperthyroid patients 460 without any previous treatment were enrolled in a 9-year prospective, randomized, open-label blinded endpoint study and randomly assigned to receive either 131I or ATD. Follow-up was 98.4+/-5.5 months. The primary outcome was euthyroidism, persistent hyperthyroidism, recurrence, and hypothyroidism. RESULTS: Euthyroidism was achieved in 69.9 and 41.2% using either 131I or ATD, 2.4 and 19.2% remained hyperthyroid, hypothyroidism occurred in 21.5 and 9.0%, recurrence in 6.2 and 30.5%, respectively. Time to cure was shorter with 131I (44.8 vs. 74.8 months, P<0.01). Goiter size extended time to cure. Hard goiter, complications, or ophthalmopathy were protective against hypothyroidism after 131I therapy. Large goiters or long courses of hyperthyroidism predicted failure of ATD treatment. CONCLUSION: This study showed a shorter cure time using 131I. Time to remission in ATD patients was shorter during the first 9 months. Thereafter, the 131I group showed a higher remission rate. Low long-term hypothyroidism and low recurrence or persistent hyperthyroidism rates were achieved with our 131I dose regimen, regardless of the underlying disease. Lesser 131I activity was used as compared with current guidelines. Within limitations, our concept may simplify procedures in other geographical regions.
Dan Yun Chen; Jin Jing; Peter F Schneider; Tang Hua Chen
Related Documents :
8573893 - Treatment of secondary hyperparathyroidism with low dose intermittent calcitriol in hem...
1304283 - Iopanoic acid as an adjunct to carbimazole in the management of hyperthyroidism.
25097673 - Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference ...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Nuclear medicine communications     Volume:  30     ISSN:  0143-3636     ISO Abbreviation:  Nucl Med Commun     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-02-05     Completed Date:  2009-03-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8201017     Medline TA:  Nucl Med Commun     Country:  England    
Other Details:
Languages:  eng     Pagination:  160-8     Citation Subset:  IM    
Hyperthyroidism Treatment Center, Dongshan Division, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antithyroid Agents / administration & dosage*
Dose-Response Relationship, Drug
Double-Blind Method
Hyperthyroidism / drug therapy*,  radiotherapy*
Iodine Radioisotopes / administration & dosage*
Longitudinal Studies
Radiopharmaceuticals / administration & dosage,  therapeutic use
Radiotherapy Dosage
Treatment Outcome
Reg. No./Substance:
0/Antithyroid Agents; 0/Iodine Radioisotopes; 0/Radiopharmaceuticals

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diagnostic efficacy of a low-dose 32-projection SPECT 99mTc-sestamibi myocardial perfusion imaging p...
Next Document:  Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule.